These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 5466970)

  • 1. Drugs on the market.
    JAMA; 1970 Feb; 211(7):1177. PubMed ID: 5466970
    [No Abstract]   [Full Text] [Related]  

  • 2. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 3. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
    WESTON JK; WESTON K
    Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceutical drugs-the good and the not so good: together, we can make it better.
    Campbell AW
    Altern Ther Health Med; 2014; 20(1):9-11. PubMed ID: 24445351
    [No Abstract]   [Full Text] [Related]  

  • 5. [FOODS-DRUGS-POISONS. ELEMENTS OF DEFINITION].
    TREMOLIERES J
    J Med Chir Prat; 1964 Oct; 135():339-47. PubMed ID: 14225293
    [No Abstract]   [Full Text] [Related]  

  • 6. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Standardization of drug names.
    Lewis JR
    JAMA; 1974 Jul; 229(5):559-60. PubMed ID: 4406902
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide and beyond: some recommendations regarding public policies toward the ethical drug industry.
    Schifrin LG
    Int J Health Serv; 1974; 4(1):147-55. PubMed ID: 4829893
    [No Abstract]   [Full Text] [Related]  

  • 9. Standardization of drug names.
    Allan FM
    JAMA; 1974 Jul; 229(5):541-3. PubMed ID: 4406898
    [No Abstract]   [Full Text] [Related]  

  • 10. Program seeks to enlist physicians to flag questionable promotion of drugs.
    Mitka M
    JAMA; 2010 Jul; 304(1):28-9. PubMed ID: 20606140
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
    Gostin LO
    JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642
    [No Abstract]   [Full Text] [Related]  

  • 12. Will you be ready?
    Welch AM
    J Am Pharm Assoc; 1972 Nov; 12(11):563-4. PubMed ID: 4634968
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drugs and the public].
    Takemi T
    Nihon Ishikai Zasshi; 1968 Jun; 59(12):1597-601. PubMed ID: 5750489
    [No Abstract]   [Full Text] [Related]  

  • 14. A perspective on US drug reimportation.
    Choudhry NK; Detsky AS
    JAMA; 2005 Jan; 293(3):358-62. PubMed ID: 15657329
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic nomenclature.
    Wells BB
    JAMA; 1974 Jul; 229(5):527. PubMed ID: 4406896
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmaceutical revolution: its impact on science and society.
    Lasagna L
    Science; 1969 Dec; 166(3910):1227-33. PubMed ID: 5350314
    [No Abstract]   [Full Text] [Related]  

  • 17. Similar drug names a risky prescription.
    Hampton T
    JAMA; 2004 Apr; 291(16):1948-9. PubMed ID: 15113794
    [No Abstract]   [Full Text] [Related]  

  • 18. New drugs-miracles or mirages?
    JAMA; 2014 Jan 22-29; 311(4):423. PubMed ID: 24449329
    [No Abstract]   [Full Text] [Related]  

  • 19. The USAN nomenclature system.
    Jerome JB; Sagon P
    JAMA; 1975 Apr; 232(3):294-9. PubMed ID: 1173125
    [No Abstract]   [Full Text] [Related]  

  • 20. Issues in bringing new drugs to the market.
    Tracey WR
    Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.